"/> Novus Biologicals™ Peptide bloquant d’anticorps KA… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps KAL1

Réf. : BL-RE-048513Réf. fabricant : 18227225 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
3730
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-76580. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 18 amino acids near the center of human Anosmin.

Points forts

Source

Synthetic

(Accession #: NP_000207) The KAL1 Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-048513
Réf. fabricant18227225
Gene ID (Entrez)3730
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-76580. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneAdhesion molecule-like X-linked, ADMLXHHA, anosmin-1, KAL, KALIG1, KALIG-1, Kallmann syndrome 1 sequence, Kallmann syndrome interval gene 1, Kallmann syndrome protein, Kallmann syndrome-1 sequence (anosmin-1), KMS
Symbole de gène(s)ANOS1
Type de produitKAL1
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne18 amino acids near the center of human Anosmin
Une question, une configuration particulière ?
Contactez-nous pour un devis.